The Washington Post: The history and mystery of Purell
Use it as a supplement, or a Plan B, not as a miracle goo, say UC-affiliated experts
An article in The Washington Post describes the medical and cultural impact of hand sanitizers, predominately Purell, during the COVID-19 virus outbreak. Looking back to the late 1980s, the article explains how the company Gojo developed a clear, alcohol-based, emollient-enriched, disinfecting substance that was dispensed by a pump bottle and required no water at all.
Experts representing UC’s James L. Winkle College of Pharmacy weigh in on the efficacy and proper use of the soap and water alternative. The article quotes Pharmaceutical Sciences Alumna Kelly Dobos, a former Gojo cosmetic chemist who now sits on the college’s Board of Advisors, and Professor K.P. Ananth, director of the cosmetic sciences program at the college.
Note: Some platforms require you to disable the ad blocker.
Featured image/Pablo Delcan for The Washington Post
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.